参考文献
1: Kulkarni JA, Myhre JL, Chen S, Tam YYC, Danescu A, Richman JM, Cullis PR.
Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.
Nanomedicine. 2017 May;13(4):1377-1387. doi: 10.1016/j.nano.2016.12.014. Epub
2016 Dec 28. PubMed PMID: 28038954.
2: Kang MR, Yang G, Place RF, Charisse K, Epstein-Barash H, Manoharan M, Li LC.
Intravesical delivery of small activating RNA formulated into lipid nanoparticles
inhibits orthotopic bladder tumor growth. Cancer Res. 2012 Oct 1;72(19):5069-79.
doi: 10.1158/0008-5472.CAN-12-1871. Epub 2012 Aug 6. PubMed PMID: 22869584.
3: Lee JB, Zhang K, Tam YY, Tam YK, Belliveau NM, Sung VY, Lin PJ, LeBlanc E,
Ciufolini MA, Rennie PS, Cullis PR. Lipid nanoparticle siRNA systems for
silencing the androgen receptor in human prostate cancer in vivo. Int J Cancer.
2012 Sep 1;131(5):E781-90. doi: 10.1002/ijc.27361. Epub 2012 Jan 3. PubMed PMID:
22095615.
4: Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DW, Stebbing D,
Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG, Wong KF,
Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M,
Weinstein MJ, Chen Q, Alvarez R, Barros SA, De S, Klimuk SK, Borland T,
Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de
Fougerolles A, MacLachlan I, Cullis PR, Madden TD, Hope MJ. Rational design of
cationic lipids for siRNA delivery. Nat Biotechnol. 2010 Feb;28(2):172-6. doi:
10.1038/nbt.1602. Epub 2010 Jan 17. PubMed PMID: 20081866.
